$AGIO Recent News Four signs that would indicate a new

New Post Public Reply Private Reply Replies (0) Message Board

Jan 27, 2015 at 10:48 AM

$AGIO Recent News

Four signs that would indicate a new uptrend 2:52 p.m. Dec. 16, 2014 - The Trading Deck
Is the next Cisco out there? 3:24 p.m. Nov. 25, 2014 - The Trading Deck
Growth stocks provide litmus test for stock market 3:13 p.m. Nov. 18, 2014 - The Trading Deck
The double-edged sword of growth-stock speculation 2:30 p.m. Nov. 14, 2014 - The Trading Deck
Two biotech leaders to watch 1:13 p.m. Oct. 28, 2014 - The Trading Deck
6 stocks to watch 2:10 p.m. Oct. 22, 2014 - The Trading Deck
S&P 500 returns to scene of the breakdown 9:56 a.m. Oct. 3, 2014 - Michael Ashbaugh
15 small-cap stocks Goldman Sachs says are worth a look 10:51 a.m. July 22, 2014 - blogs.marketwatch.com
Stock futures drop as earnings season looms 8:20 a.m. April 7, 2014 - Sara Sjolin
Agios shares rally 6.4% premarket after upbeat trial results 6:28 a.m. April 7, 2014 - Sara Sjolin

3 High-Flying Health Care Stock IPOs To Watch In 2015 4:09 p.m. Jan. 21, 2015 - Investors Business Daily
8 Biotech Stock Controversies Emerging From 'JPM15' Conference 10:18 a.m. Jan. 20, 2015 - TheStreet.com
The Week That Was: Healthcare Outlook Remains Excellent 9:44 a.m. Jan. 20, 2015 - Seeking Alpha
A Company's First Profit Can Mean Big Profits to Investors - Screen of the Week 1:00 a.m. Jan. 13, 2015 - Zacks.com
Value Investing Strategy For Biotech 12:57 p.m. Jan. 12, 2015 - Seeking Alpha
New Lifetime High Reached: Agios Pharmaceuticals (AGIO) 9:45 a.m. Jan. 12, 2015 - TheStreet.com
Why Agios Pharmaceuticals (AGIO) Could Be Positioned for a Surge? - Tale of the Tape 8:35 a.m. Jan. 12, 2015 - Zacks.com
'Free the Webcast!' Investor Transparency Gains Momentum at 'JPM15' Healthcare Confab 2:56 p.m. Jan. 9, 2015 - TheStreet.com
InsiderInsights.com Daily Round Up 1/6/15: XOMA, CODI, MNST, BBY 10:37 a.m. Jan. 8, 2015 - Seeking Alpha
Health-Care Stocks Avoid Malaise 8:34 p.m. Jan. 6, 2015 - The Wall Street Journal Interactive Edition
Jim Cramer's 'Mad Money' Recap: Knowing Where to Look for Bargains 8:25 p.m. Jan. 6, 2015 - TheStreet.com
Public Shame for Biotechs Not Webcasting 'JPM15' Breakout Sessions 3:08 p.m. Jan. 6, 2015 - TheStreet.com
Jim Cramer: Why Are You Shorting Innovative Biotech Stocks? 11:37 a.m. Jan. 6, 2015 - TheStreet.com
Biotech Stocks 2014: The Best, Worst and Fastest-Growing 8:33 a.m. Jan. 2, 2015 - TheStreet.com
Bull of the Day: Incyte (INCY) - Bull of the Day 1:00 a.m. Jan. 2, 2015 - Zacks.com
Biotech-Twitter 2014: A Look Back at the Biotech Year Through the Twitter Lens 6:00 a.m. Dec. 29, 2014 - TheStreet.com
Trade-Ideas: Agios Pharmaceuticals (AGIO) Is Today's "Dead Cat Bounce" Stock 9:57 a.m. Dec. 24, 2014 - TheStreet.com
Agios Pharmaceuticals (AGIO) in Focus: Stock Tanks 13.6% - Tale of the Tape 8:48 a.m. Dec. 24, 2014 - Zacks.com
Agios Pharmaceuticals (AGIO) Is Today's Water-Logged And Getting Wetter Stock 12:33 p.m. Dec. 23, 2014 - TheStreet.com
3 Stocks With Plunging Prices 11:00 a.m. Dec. 23, 2014 - InvestorPlace.com

Agios Announces that Celgene Has Agreed to Exercise its Option to License AG-120 under Global Strategic Collaboration 9:24 p.m. Jan. 12, 2015 - GlobeNewswire
Biotechs to Follow in 2015 off Fresh Insider Moves 10:01 a.m. Jan. 6, 2015 - ACCESSWIRE
Agios Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference on Monday, January 12 4:06 p.m. Jan. 5, 2015 - GlobeNewswire
Critical Alerts For Achillion Pharmaceuticals, Celldex Therapeutics, Halliburton, Agios Pharmaceuticals and Urban Outfitters Released By InvestorsObserver 9:31 a.m. Dec. 16, 2014 - PR Newswire - PRF
Agios Pharmaceuticals Announces Pricing of $220 Million Public Offering of Common Stock 8:42 p.m. Dec. 10, 2014 - GlobeNewswire
Agios Pharmaceuticals Announces Proposed Offering of Common Stock 4:23 p.m. Dec. 9, 2014 - GlobeNewswire
Agios Pharmaceuticals Appoints Kaye Foster-Cheek to its Board of Directors 4:02 p.m. Dec. 9, 2014 - GlobeNewswire
Agios Reports Positive Phase 1 Data in Healthy Volunteers for AG-348, a First-in-Class Investigational Medicine That Targets the Underlying Cause of Pyruvate Kinase (PK) Deficiency 1:01 p.m. Dec. 8, 2014 - GlobeNewswire
Agios Announces Celgene Decision to Extend Discovery Phase of Global Strategic Collaboration to April 2016 7:31 a.m. Dec. 8, 2014 - GlobeNewswire
Agios Announces New Data from Ongoing Phase 1 Trial of AG-221 Showing Robust Clinical Activity in Patients with Advanced Hematologic Malignancies 12:31 p.m. Dec. 7, 2014 - GlobeNewswire
Critical Alerts For Agios Pharmaceuticals, Target, Dollar General, Lululemon and Costco Released By InvestorsObserver 9:31 a.m. Nov. 20, 2014 - PR Newswire - PRF
Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120 as a Single Agent in Advanced Acute Myeloid Leukemia (AML) 6:01 p.m. Nov. 18, 2014 - GlobeNewswire
Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results 7:01 a.m. Nov. 7, 2014 - GlobeNewswire
Agios Pharmaceuticals to Present Clinical and Preclinical Data at the 2014 American Society of Hematology Annual Meeting 9:09 a.m. Nov. 6, 2014 - GlobeNewswire
Critical Alerts For LinkedIn, Imperva Inc, Norfolk Southern, Halliburton and Agios Pharmaceuticals Released By InvestorsObserver 9:31 a.m. Nov. 3, 2014 - PR Newswire - PRF
Agios Pharmaceuticals to Webcast Conference Call of Third Quarter 2014 Financial Results on November 7, 2014 7:32 a.m. Oct. 27, 2014 - GlobeNewswire
Agios Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of AG-221 in Patients with Advanced Solid Tumors with an IDH2 Mutation 7:31 a.m. Oct. 21, 2014 - GlobeNewswire
Agios Pharmaceuticals Announces Initiation of Four Expansion Cohorts in Phase 1 Study of AG-221 6:30 a.m. Oct. 15, 2014 - GlobeNewswire
Agios Pharmaceuticals to Webcast R&D Day on October 15, 2014 8:02 a.m. Oct. 6, 2014 - GlobeNewswire
Earnings Release Schedules, Data Presentation, Regulatory Approvals, and Strategic Collaboration - Research Reports on Covidien, Biogen, Amgen, Agios and Baxter 7:55 a.m. Oct. 1, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

ASTS Faces Crucial Deadline Amidst Legal Turmoil

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Darden Faces Class Action Over Reimbursement Failures

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Alaska's Insurance Maze: Coverage Over Cheap Policies

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

DIRECTV Bags New NHL Deals: Stakes for Sports Fans

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Likang's Bold Move: Cancer Immunotherapy at AD Summit

Cancer Care Takes Center Stage Kicking off with a bang in Abu Dhabi, Likang Life Sciences has made a splash in the world of personalized cancer immunotherapy. The Abu Dhabi Future Health Summit 2026 served as the backdrop for this bold move, lighting up discussions with their AI-enabled innovations. Likang's showing at the Summit wasn't just another walk in the park—it...

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Aluminum Design Fumble: Geometry Over Wall Thickness

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...